GABA B receptors are unique among G-protein-coupled receptors (GPCRs) in their requirement for heterodimerization between two homologous subunits, GABA B1 and GABA B2 , for functional expression. Whereas GABA B1 is capable of binding receptor agonists and antagonists, the role of each GABA B subunit in receptor signaling is unknown. Here we identified amino acid residues within the second intracellular domain of GABA B2 that are critical for the coupling of GABA B receptor heterodimers to their downstream effector systems. Our results provide strong evidence for a functional role of the GABA B2 subunit in G-protein coupling of the GABA B receptor heterodimer. In addition, they provide evidence for a novel "sequential" GPCR signaling mechanism in which ligand binding to one heterodimer subunit can induce signal transduction through the second partner of a heteromeric complex.
GABA B receptors are G-protein-coupled receptors (GPCRs) that mediate slow synaptic inhibition in the brain and spinal cord (for review, see Bowery, 1993; Kerr and Ong, 1995; Couve et al., 2000) . They are unique among type C GPCRs in that they are heterodimers of GABA B1 (Kaupmann et al., 1997) and GABA B2 subunits (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998; Kuner et al., 1999; Ng et al., 1999) , and it is now generally accepted that each subunit is unable to form a functional receptor when expressed in isolation (Kaupmann et al., 1997; Jones et al., 1998; White et al., 1998; Ng et al., 1999) . With respect to GABA B1 , this is attributable to its retention within the endoplasmic reticulum on homomeric expression (Couve et al., 1998; Calver et al., 2000; Filippov et al., 2000; Margeta-Mitrovic et al., 2000) . In this context, GABA B2 has been shown to play a key role in trafficking the GABA B1 subunit to the cell surface (Couve et al., 1998; Filippov et al., 2000) . This exposes the N-terminal ligand binding domain of GABA B1 , which is not present in GABA B2 (Galvez et al., 2000a,b) , enabling it to bind extracellular agonist and subsequently activate downstream signaling pathways. Interestingly, it has been shown recently that C-terminal GABA B1 mutants, which are expressed on the cell surface in the absence of GABA B2 , are completely nonfunctional, despite their ability to bind GABA (Calver et al., 2000; Margeta-Mitrovic et al., 2000) . GABA B receptor function is restored, however, when these mutants are coexpressed with GABA B2 , demonstrating that the GABA B2 subunit may not only be important for correct trafficking of GABA B1 but also for the mediation of agonist-induced G-protein coupling. This hypothesis has been given additional strength by a recent report by Galvez et al. (2001) , demonstrating that the extracellular domain of GABA B2 is essential for agonist activation of the heterodimeric receptor.
Mechanisms for G-protein coupling have been investigated widely for members of the rhodopsin -␤-adrenergic GPCR family. Growing evidence suggests that the second and third intracellular loops are critical interaction sites important for both G-protein coupling and selectivity. In addition, these intracellular domains have been demonstrated to be important for G-protein coupling of type C GPCRs, such as metabotropic glutamate receptors (mGluRs) (Gomez a et al., 1996; Francesconi and Duvoisin, 1998) . At present, the role of the two GABA B subunits in G-protein coupling and downstream signal transduction is unknown. Here, using a site-directed mutagenesis approach, we investigated the importance of residues in the second intracellular loop (il2) of GABA B1 and GABA B2 subunits. We demonstrated that mutations within il2 of GABA B2 can dramatically decrease responses of the heterodimer complex to agonist, to the extent that receptor signaling can be effectively abolished by the introduction of three negatively charged residues into this region. In contrast, reciprocal mutations made in il2 of the GABA B1 subunit have no apparent effect on heterodimer signaling. These results are consistent with a model in which agonists bind to the GABA B1 subunit, resulting in signal transduction via G-protein coupling through the GABA B2 subunit. This would therefore suggest the existence of a novel "sequential and sideways" signaling cascade that may be of relevance to the growing number of reported GPCR heterodimers (Milligan and Rees, 2000) .
(referred to as GABA B1 KQE ) . Mutagenesis experiments were performed using the Quikchange site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to the instructions of the manufacturer, and all amino acid changes were confirmed by f ull double-stranded sequencing.
C -terminal truncates (from amino acid 747 of GABA B1 ) of the GABA B1 mutant constructs (glutamate to lysine only) were made by PCR amplification using forward primer 5Ј-CCCGAATTCATGGG GCCCGGGGCC -3Ј and reverse primer 5Ј-CCCAAGC TTCC TCG GGTGATCAGCC TG-3Ј. A GABA B1N/2 chimera was generated by ligation of two PCR products (GABA B1b 1-470 and GABA B2 479 -954). PCR amplification was performed using forward primer 5Ј-CCCGA ATTCATGGGGCCCGGGGCC -3Ј and reverse primer 5Ј-CCCAAGC TTC TGGTCAGC TGGGGGGGAC -3Ј to generate fragment GABA B1b 1-470. PCR amplification with forward primer 5Ј-CCCAAGC TT ATCATCC TGG AGCAGC TGCGGAAG-3Ј and reverse primer 5Ј-CCCC TCGAGTTACAGGCCCGAGACCA TGAC TC -3Ј was used to generate fragment GABA B2 479 -954. All constructs were cloned into the eukaryotic expression construct pcDNA3.1 (Invitrogen, Paisley, UK). Schematic representations of these constructs are shown in Figure 1c .
Transfection. Human embryonic kidney 293 (H EK293) cells were transfected with either wild-type (wt) or mutant GABA B1 -or GABA B2 -containing plasmids using Lipofectamine Plus (Life Technologies, Paisley, UK) according to the instructions of the manufacturer. C ells were maintained in Minimal Essential Medium supplemented with 10% fetal bovine serum and 1% nonessential amino acids (all from Life Technologies). After transfection, cells were left for 24 hr before being subcultured for immunocytochemistry or the C a 2ϩ mobilization assay. The GABA B1b /GABA B2 cell line was generated in Chinese hamster ovary cells as described previously . The GABA B2 cell line was generated in H EK293 cells by transient transfection of the GABA B2 cDNA as described above and selection of positive cells in 800 g /ml G418.
Immunoc ytochemistr y. H EK293 cells transfected with either wild-type or mutant constructs were subcultured onto glass coverslips, fixed with 4% paraformaldehyde, and then either permeabilized with 0.1% Triton X-100 for 10 min or washed with PBS. C ells were incubated with primary antibody [anti-c-myc, 1:5000; anti-HA, 1:5000 (Boehringer Mannheim, Brüssel, Belgium); and anti-GABA B1b , 1:1000] for 60 min and washed, and then secondary antibody [goat anti-mouse IgG FI TC for c-myc; goat anti-rat IgG FI TC for HA (Sigma, St. L ouis, MO); and goat ant-rabbit IgG FI TC for GABA B1b ] was used at 1:100 dilution for 60 min. C ells were finally washed, mounted onto glass slides using C itifluor (C itifluor L td., L ondon, UK), and viewed using a Leica (Nussloch, Germany) confocal microscope. Ca 2ϩ mobilization assay. Transfected cells were seeded into 96-well plates at a density of 50,000 cells per well and incubated at 37°C in 5% CO 2 for 24 hr before use. The intracellular C a 2ϩ mobilization in response to agonist was then measured as described previously (C alver et al., 2000) . The data were iteratively curve fitted using a four parameter logistic model (Bowen and Jerman, 1995) as mean Ϯ SEM (with each data point being determined in triplicate) of one representative experiment. Significance of data were assessed using a one-way ANOVA, followed by post hoc t test (least square difference). Data were considered significant if p Ͻ 0.05.
Radioligand binding. Membranes from transfected cells were prepared, and radioligand binding to [ 3 H]CGP54626 was performed as described previously (C alver et al., 2000) . The concentration of drug-inhibitingspecific radioligand binding by 50% (IC 50 ) was determined by iterative curve fitting (Wood et al., 2000) . pK i values (the negative log 10 of the molar K i ) for receptor binding were then calculated from the IC 50 values as described by Cheng and Prusoff (1973) using K D values determined previously in saturation binding studies (3 nM). B max values were calculated from the specific bound accounting for receptor occupancy at this radioligand concentration using the Hill -Langmuir adsorption isotherm. Data are expressed as the mean Ϯ SEM of at least three separate experiments from two independent sets of transfections.
[ 35 S]GTP␥S binding assays. C ells were homogenized in 20 mM H EPES and 10 mM EDTA, pH 7.4 (4°C), and centrif uged at 48,000 ϫ g for 20 min at 4°C. Membrane pellets were rehomogenized in 20 mM H EPES and 0.1 mM EDTA, pH 7.4, (4°C). The pellet was recentrif uged as described above, the supernatant was discarded, and the pellet was resuspended in 20 mM H EPES and 0.1 mM EDTA and stored at Ϫ80°C until required.
[ 35 S]GTP␥S binding assays were performed in a 20 mM H EPES buffer, Figure 1 . Intracellular loop sequence alignments and summary of GABA B1 and GABA B2 constructs. a, Alignment of the second and third intracellular loops of GABA B1 (GABAB1) and GABA B2 (GABAB2) subunits with members of the mGluR family. The alignment was produced in Alscript using HMMALIGN and the G-protein-coupled receptors database (GPCRDB) (Barton, 1993; Horn et al., 1998 pH 7.4, containing 3 mM MgC l 2 and 100 mM NaC l. C ell membranes were preincubated with 10 M GDP, and increasing concentrations of GABA or baclofen for 30 min at 30°C and then 0.1 nM [ 35 S]GTP␥S was added to each well and incubated for an additional 30 min. Nonspecific binding was determined in the presence of 20 M GTP␥S. The incubation was terminated by rapid filtration through J. Whatman glass fiber filters (GF/ B) (Semat International, St. Albans, UK) and washed with 3 ml of ice-cold H EPES buffer, pH 7.4, containing 3 mM MgC l 2 . Radioactivity was determined by liquid scintillation spectrometry using a Packard (Meridian, C T) TopCount.
cA MP accumulation assays. cAM P levels in cells were determined by radioimmunoasay (SM P004; N EN, Boston, M A) according to the instructions of the manufacturer. In brief, cells were washed once with Ca 2ϩ -free PBS, scrapped up in the same buffer, and pelleted by a 5 min centrif ugation at 400 ϫ g. The pellet resuspended in manufacturers stimulation buffer, and ϳ50,000 cells were added to the appropriate wells of the N EN flash plates together with 10 M forskolin, plus increasing concentration of agonist. Plates were incubated for 15 min at 37°C, before the addition of the manufacturers detection mixture containing [
125 I]cAM P tracer (0.16 C i /ml) to the wells. Plates were covered and left for 24 hr before counting on a Packard TopCount.
Neuron preparation and cDNA injection. Neuron isolation and injection procedures have been described previously (C aulfield et al., 1994; Couve et al., 1998; Filippov et al., 2000) . Briefly, single superior cervical ganglion (SCG) neurons were dissociated from 15-to 19-d-old rats and plated on laminin-coated glass coverslips. Five hours after plating, neurons were microinjected into the nucleus with plasmids carrying cDNAs for the GABA B receptor subunits, in addition to a plasmid encoding green fluorescent protein to subsequently identif y successf ully injected cells. Electrophysiological recordings were routinely made 16 -20 hr after injection at room temperature (20°C). Ca 2ϩ channel current recording. Currents through voltage-gated C a 2ϩ channels were recorded using the conventional whole-cell patch-clamp method as described previously (C aulfield et al., 1994; Couve et al., 1998; Filippov et al., 2000) . C a 2ϩ channel currents were routinely evoked every 20 sec with 100 msec depolarizing rectangular test pulse to 0 mV from a holding potential of Ϫ90 mV. C a 2ϩ channel current amplitudes were measured isochronally 10 msec from the onset of the rectangular test pulse, i.e., near to the peak of the control current. As reported previously (Filippov et al., 2000) , currents were primarily N-type with negligible contribution by L -type channels. A racemic mixture of (ϩ)-and (Ϫ)-baclofen was used in all experiments. Data are presented as means Ϯ SEM as appropriate. Student's test (unpaired) was applied to determine statistical significance. Difference were considered significant if p Ͻ 0.05.
RESULTS

Sequence analysis of the second and third intracellular loops of GABA B1 and GABA B2
Using sequence alignments, we compared residues in the second and third intracellular loops of the GABA B subunits and the related type C mGluRs (Fig. 1a) . The basic residue Arg 775 in the third intracellular loop (il3) of mGluR1 has been shown to be important for coupling to G-proteins (Francesconi and Duvoisin, 1998) and is conserved throughout the mGluR family and also in GABA B2 (Fig. 1a) . In contrast, the corresponding residue in GABA B1 is a lysine. In il2 of all of the mGluRs, there is a conserved lysine at position 690 (numbered with respect to mGluR1), except for mGluR2 in which the equivalent residue is an arginine, and this basic residue has been shown to be crucial for the interaction of the mGluRs with their respective G-protein (Francesconi and Duvoisin, 1998) . Similarly, we noted that GABA B2 also has a basic lysine at this key position. This is in contrast to the GABA B1 subunit, in which the acidic amino acid glutamate is substituted for this lysine, resulting in a reversal of charge at this site. These findings may be of functional relevance, because it has been proposed previously that electrostatic interactions between positive charges in the intracellular domains of GPCRs may be important for coupling to a negatively charged face of the G-protein (Fanelli et al., 1998) .
Amino acids in the second intracellular loop of GABA B2 are critical for GABA B receptor signaling through the chimeric G-protein G qi5
Based on our sequence analysis of the GABA B1 and GABA B2 intracellular loops, we targeted three amino acid residues (K586, M587, and K590) within il2 of GABA B2 for mutagenesis studies (Fig. 1a,b) . These residues were mutated to glutamates either individually or in combination to give a series of single, double, or triple mutants:
, and GABA B2 tripleE (Fig. 2a) . When transfected into HEK293 cells in isolation, both wild-type and mutant GABA B2 subunits could be detected on the cell surface in the absence of membrane permeabilization (Fig. 2b) . In addition, coexpression of each GABA B2 mutant with wtGABA B1 demonstrated that each mutant retained its ability to traffic the GABA B1 subunit to the cell surface (Fig.  2b) . Having demonstrated that these mutants behaved normally in terms of trafficking to the cell surface, we next tested the ability of the mutated GABA B2 subunits to functionally couple to Gproteins when coexpressed with the wild-type GABA B1 subunit. Although GABA B receptors are known to inhibit adenylyl cyclase activity by preferentially coupling to G o/i , they can also be made to signal via the phospholipase C pathway when coexpressed with the chimeric G-protein G qi5 (Franek et al., 1999; Wood et al., 2000) . Activation of this pathway results in a mobilization of intracellular Ca 2ϩ stores, which can then be measured on a fluorimetric imaging plate reader (FLIPR). Coexpression of wtGABA B1 and wtGABA B2 subunits with G qi5 in HEK293 cells resulted in a robust Ca 2ϩ mobilization in response to GABA (pEC 50 , 7.19 Ϯ 0.06; n ϭ 36). In the same system, expression of wtGABA B1 with either GABA B2 K586E or GABA B2 K590E resulted in significantly reduced pEC 50 values when compared with coexpression with wtGABA B2 (6.35 Ϯ 0.07, n ϭ 11, p Ͻ 0.001; and 6.07 Ϯ 0.04, n ϭ 12, p Ͻ 0.001, respectively) (Fig. 2c) . Expression of wtGABA B1 with the double-mutant GABA B2 K586E / M587E resulted in additional reduction of the observed pEC 50 in response to GABA (5.40 Ϯ 0.11; n ϭ 10; p Ͻ 0.001). In contrast to the other GABA B2 mutants studied, expression of GABA B2 tripleE in combination with wtGABA B1 resulted in no detectable responses in this functional assay (n ϭ 12) (Fig. 2c) .
Based on these results, we next prepared mutations in the second intracellular loop of GABA B2 that would help us investigate the relative importance of losing or gaining positive charge within this stretch of five amino acids. To do this, we examined the effects of changing residues K586, M587, and K590 to neutral alanines instead of negatively charged glutamates. As with the previous set of glutamate mutants, cell surface expression of each of the alanine mutants in isolation appeared no different to that of the wtGABA B2 subunit (data not shown). Expression of wt-GABA B1 and G qi5 in combination with GABA B2 K586A or GABA B2
K590A resulted in significantly reduced pEC 50 values when compared with coexpression with wtGABA B2 (6.30 Ϯ 0.13, n ϭ 8, p Ͻ 0.001; and 5.75 Ϯ 0.08, n ϭ 10, p Ͻ 0.001, respectively) (Fig. 2d) . Coexpression with the double-mutant GABA B2 K586A / M587A resulted in similar significant reduction in pEC 50 in response to GABA (6.16 Ϯ 0.07; n ϭ 8; p Ͻ 0.001). In contrast to the other GABA B2 mutants studied, and similar to the GABA B2 tripleE mutant, expression of GABA B2 tripleA in combination with wtGABA B1 resulted in no detectable responses in this functional assay (Fig. 2d) .
Mutations in the second intracellular loop of GABA B2 have no effect on agonist or antagonist binding
Having shown a marked effect on GABA B receptor signaling after mutation of selected residues within the second intracellular loop of GABA B2 , we wanted to see whether the agonist and antagonist binding properties of the mutant receptor heterodimer were consistent with that of the wild-type receptor. Analysis of membrane homogenates expressing each GABA B2 mutant in combination with wtGABA B1 had no effect on the ability of GABA to displace the antagonist CGP54626 in competition binding assays. The potency of GABA observed in homogenates prepared from cells expressing GABA B2 K586E , GABA B2 K590E , GABA B2 K586E / M587E , or GABA B2 tripleE with wtGABA B1 subunit was not significantly different from that observed when the wild-type GABA B2 subunit was coexpressed with the GABA B1 subunit (pK i values of 4.57 Ϯ 0.17, 4.22 Ϯ 0.05, 4.48 Ϯ 0.22, 4.84 Ϯ 0.54, and 4.37 Ϯ 0.12, respectively; n ϭ 3) (Fig. 2e) The demonstration that mutation of specific residues within the second intracellular loop of GABA B2 can have pronounced effects on GABA B signaling through G qi5 led us to examine the functional importance of similarly positioned residues within the GABA B1 subunit. We therefore studied the consequences of mutating the stretch of negative amino acids found in the second intracellular loop of GABA B1 and in a similar position to those residues mutated previously in GABA B2 (Fig. 3a) . Each of the mutants GABA B1 E579K , GABA B1 E583K , GABA B1 E579K / E580K , and GABA B1 tripleK were transfected into HEK293 cells with and without wtGABA B2 . In the absence of GABA B2 , neither wt or mutant GABA B1 variants were expressed at the cell surface ( Fig.  3b and data not shown) . However, when coexpressed with the GABA B2 subunit, cell surface expression of all GABA B1 mutants was observed as expected ( Fig. 3b and data not shown) . These experiments therefore suggest that mutation of these acidic residues in the second intracellular loop of GABA B1 do not affect trafficking of the subunit to the surface by GABA B2 . We then tested the ability of these constructs to activate G qi5 in response to GABA. Cell surface expression of GABA B subunits was examined by immunofluorescence using an anti-myc antibody for GABA B1 (i-v) and an anti-HA antibody for GABA B2 (vi-x (Fig. 3c) . This suggests that these acidic residues are not critical in the signaling of the GABA B1 receptor dimer through G qi5 .
Addition of positively charged residues to the second intracellular loop of a cell surface-expressed GABA B1 is not sufficient for receptor function in the absence of GABA B2 Although mutation of acidic residues in the second intracellular loop of GABA B1 appeared to have no functional effect with respect to heterodimer signaling, we also wanted to test the function of GABA B1 mutants when expressed on the cell surface in the absence of GABA B2 . We and others have shown previously that removal of the C-terminal domain of the GABA B1 subunit results in its cell surface expression in the absence of GABA B2 . However, despite this cell surface expression, the GABA B1 subunit remains ineffective in coupling to downstream effector systems in the absence of GABA B2 (Calver et al., 2000; MargetaMitrovic et al., 2000) . In this set of experiments, we therefore produced four C -terminal truncates: GABA B1C -E579K , GABA B1C -E579K / E580K , GABA B1C -E583K , or GABA B1C -tripleK . E xpression of these mutants showed that they were all able to reach the cell surface in the absence of GABA B2 (Fig. 3b and data not shown). We then compared the ability of each GABA B1 C-terminal truncate mutant to couple to G qi5 after stimulation by GABA. All of the GABA B1 mutants tested were nonfunctional when expressed alone (n ϭ 4) ( Fig. 3d and data not shown) . In contrast, expression of each truncated GABA B1 mutant gave a robust signal when coexpressed with GABA B2, no different to that seen with wtGABA B1 (data not shown). This suggests that removal of negatively charged glutamic acid residues within the second intracellular loop of GABA B1 is not sufficient to allow signaling and strengthens the argument that the GABA B2 subunit is absolutely necessary for G-protein signaling.
Positively charged amino acids in the second intracellular loop of GABA B1 are not critical for GABA B receptor signaling through G qi5 We also noted when aligning the GABA B1 and GABA B2 il2 sequences that there were five positively charged lysine residues in this region of GABA B1 , although they do not directly align with the positive residues within il2 of GABA B2 that we implicated in G-protein coupling. We therefore wanted to exclude the possibility that these amino acids might be involved in receptor signaling. We studied the effects of mutating the five lysine residues in il2 of GABA B1 to neutral alanines and/or negatively charged glutamates, both in pairs and all five together (Fig. 4a) . Each of the mutants GABA B1 K577/578A , GABA B1 K581/582A , GABA B1 KQA , and GABA B1 KQE were transfected into HEK293 cells together with GABA B2 . This resulted in cell surface expression of all of the GABA B1 mutants as expected (Fig. 4b) . We then tested the ability of these constructs to activate G qi5 in response to GABA. Coexpression of GABA B2 with GABA B1 K577/578A , GABA B1 K581/582A , GABA B1 KQA , or GABA B1 KQE resulted in the expression of functional GABA B receptors. Neither of the double mutations (GABA B1 K577/578A or GABA B1 K581/582A ) produced any significant changes in the potency of GABA when compared with the wild-type receptor, and although the potency of GABA at the quintuple mutant subunits (GABA B1 KQA and GABA B1 KQE ) was slightly lower than the wild type, this was a very minor effect when compared with the mutations in GABA B2 (pEC 50 values for wtGABA B1 , 7.19 Ϯ 0.06, n ϭ 36; GABA B1 K577/ 578A, 7.28 Ϯ 0.04, n ϭ 9; GABA B1 K581/582A , 7.17 Ϯ 0.08, n ϭ 9; GABA B1 KQA , 6.74 Ϯ 0.08, n ϭ 12; and GABA B1 KQE , 6.76 Ϯ 0.03, n ϭ 9) (Fig. 4c) . These data suggest that the basic residues Cell surface expression of GABA B1 subunits was examined by immunofluorescence using an anti-myc antibody in the absence (i, iii, iv) or presence (ii, v) of a permeabilizing detergent. GABA B1 is only found at the cell surface when expressed with GABA B2 , as shown with the GABA B1 tripleK construct (i-iii). The C-terminally truncated GABA B1 is expressed at the cell surface in the absence of GABA B2 , as shown with the GABA B1C -tripleK mutant (iv, v in il2 of GABA B1 are also not critical for the signaling of the GABA B receptor dimer through G qi5 .
Exchanging charged residues between the second intracellular loops of GABA B1 and GABA B2 abolishes GABA B receptor functional coupling to G-proteins Because GABA B2 tripleE when coexpressed with the wild-type GABA B1 produced a nonfunctional receptor, we coexpressed GABA B2 tripleE with GABA B1 tripleK in HEK293 cells. Despite both subunits being expressed at the cell surface (Fig. 5a ), no functional response was detected in the Ca 2ϩ mobilization assay (n ϭ 8) (Fig. 5b) . This suggests that GABA B2 is essential for G-protein coupling in the GABA B receptor.
Amino acids in the second intracellular loop of GABA B2 are critical for GABA B receptor signaling through endogenous G-proteins in superior cervical ganglion cells
It was important to determine that the functional effects observed using our GABA B2 mutant constructs in conjunction with G qi5 could be reproduced in an effector system coupled to endogenously expressed G-proteins. We demonstrated previously that SCG neurons express only the GABA B1 subunit. However microinjection of GABA B2 constructs into these neurons results in the expression of functional GABA B receptors that inhibit Ca 2ϩ channels (Filippov et al., 2000) . Microinjecton of GABA B2
K590E
and GABA B2 tripleE resulted in cell surface expression of GABA B2 (Fig. 6a) and GABA B1 subunits (data not shown). Expression of the wtGABA B2 subunit and stimulation by baclofen resulted in an ϳ53 Ϯ 2.02% inhibition of voltage-activated Ca 2ϩ currents (Fig. 6b,c) , as measured 10 msec after the voltage pulse. Expression of GABA B2 K590E resulted in significantly reduced inhibition of Ca 2ϩ currents when compared with wt-GABA B2 (42 Ϯ 1.92%) inhibition (Fig. 6b-d) . In contrast to the other mutants studied, injection of the GABA B2 tripleE mutant resulted in no baclofen-stimulated inhibition of Ca 2ϩ channel opening above that observed in mock-injected neurons. This demonstrates that the GABA B2 tripleE mutant, in conjunction with endogenous GABA B1 , forms a completely nonfunctional GABA B receptor (Fig. 6b,c) .
The GABA B2 subunit alone is unable to functionally respond to GABA It is known that the GABA B1 subunit contains a binding site for GABA in its N-terminal domain (Malitschek et al., 1999) , but it is still unclear from published work as to whether GABA B2 is capable of binding and responding to GABA on its own. We therefore generated a GABA B2 stable cell line in HEK293 cells, in which we confirmed GABA B2 expression on the cell surface by both immunocytochemistry and Western blotting (data not shown). We were unable to observe any [
35 S]GTP␥S binding during stimulation with GABA up to a concentration of 1 mM (Fig. 7a) . Similarly, we were unable to demonstrate any inhibition of forskolin-stimulated adenylate cyclase activity in these cells in response to GABA at a concentration of up to 100 M (Fig. 7b) . In cell lines expressing both GABA B1 and GABA B2 on the other hand, we were readily able to demonstrate functional coupling using both of these techniques with the pharmacology expected from recombinant GABA B receptors (Fig. 7a,b) .
The N-terminal domain of GABA B2 is also necessary for normal GABA B receptor signaling To investigate whether the N-terminal domain of GABA B2 is important in normal GABA B receptor function, we made a chimeric GABA B2 construct by replacing the N-terminal binding domain of GABA B2 with that of GABA B1 . Expression of this GABA B1N/2 subunit was clearly observed on the cell surface, and furthermore it retained the ability to traffic wtGABA B1 to the cell surface (Fig. 7c) . However, functional analysis of cells expressing both GABA B1N/2 and wtGABA B1 exhibited a complete lack of response to GABA (n ϭ 4) (Fig. 7d) . This suggests that the N-terminal domain of GABA B2 may also be important in the mediation of receptor responses to GABA, despite the fact that this subunit does not actually bind GABA.
DISCUSSION
GABA B receptors are the only members of the type C family of GPCRs that have been shown to function as heterodimers. They are also distinct from other reported GPCR heterodimers in which both members of the heterodimer complex are able to form functional receptors when expressed as monomers (Jordan and Devi, 1999; AbdAlla et al., 2000; Gines et al., 2000; Gomes et al., 2000; Rocheville et al., 2000) . In this study, we wanted to further analyze the role of each GABA B subunit with respect to G-protein coupling and signal transduction, focusing on residues within the second and third intracellular loops. Residues within these domains have been demonstrated previously to be critical for G-protein interactions in a number of receptors. More specifically, recent studies on the functional roles of the cytoplasmic domains of rhodopsin have suggested that the third intracellular loop contains sites important in determining G-protein specificity, whereas the second intracellular loop contains regions essential for G-protein activation (Yamashita et al., 2000) . Sequence comparison of residues in il2 and il3 for both the GABA B subunits and the related mGluRs highlighted clear differences between GABA B1 and GABA B2 of potential relevance for G-protein coupling (Fig. 1a) , suggesting that it may be GABA B2 rather than GABA B1 that is involved in the coupling of the GABA B receptor to G-proteins and downstream signaling. Furthermore, comparison of 46 il2 sequences from various species demonstrated that all of the mGluRs and GABA B2 contained fewer than two negatively charged residues within this loop. This is in sharp contrast to GABA B1 , which contains four negatively charged residues. This may be of particular relevance in the context of modeling studies by Fannelli et al. (1998) , who investigated the electrostatic complimentarity of receptor-G-protein complexes. These studies favor a model whereby "opening" of the cytosolic domains of the receptor allows for an interaction between the electrostatically positive surface of the domains of the receptor and the negatively charged surface of the G ␣ subunit (Higgs and Reynolds, 2001) . In this respect, it is of interest that the electrostatic potential of G o , reported to be the predominant G-protein interacting with GABA B receptors (Leaney and Tinker, 2000) , is proposed to be one of the most negative of the G ␣ subunits (C. Reynolds, personal communication). Based on these observations, we can speculate that the negatively charged residues of the GABA B1 subunit would make it a less attractive candidate for G-protein coupling than GABA B2 .
To determine the functional role that il2 residues play in GABA B receptor function, we made a series of amino acid substitution mutants at K 586 , M 587 , and K 590 in GABA B2. Single or double substitutions of these residues to glutamate or alanine did not affect the ability of GABA B2 to reach the cell surface itself or to traffic GABA B1 to the cell surface but led to a significant reduction in agonist potency when compared with the wild-type receptor heterodimer. In addition, when all three residues were substituted by glutamates or alanines, it resulted in a receptor that was completely unresponsive to agonists. These changes in agonist efficacy were not attributable to aberrant folding of the receptor subunits or changes in binding affinity because both agonist and antagonist binding was unaltered when compared with wild-type receptor. Moreover, our binding data were consistent with immunocytochemical data and suggested that there was no significant effect on receptor expression levels. Importantly, these mutants also interfered with the physiological coupling of GABA B receptors to Ca 2ϩ channels in SCG neurons, confirming that mutation of these residues in il2 of GABA B2 was sufficient to abolish GABA B receptor signaling. These data therefore identify key residues important in G-protein coupling and activation of the receptor heterodimer and is in agreement with previous proposals suggesting that the heptahelical domains of GABA B2 , and not GABA B1 , contain these molecular determinants (Calver et al., 2001; Galvez et al., 2001) .
To further investigate the role of il2 residues in the heterodimer, we substituted the corresponding negatively charged residues in GABA B1 , E 579 , E 580 , and E 583 , to lysines. These GABA B1 mutants were all expressed on the cell surface after coexpression with GABA B2 , and all responded to agonist as effectively as the wild-type receptor heterodimer. Similarly, GABA B1 mutants in which all five positively charged lysine residues in this region were changed to either neutral or negatively charged amino acids are completely functional within heterodimers with wild-type GABA B2 . Furthermore, a number of other GABA B1 mutants we expressed all showed a complete lack of responsiveness to GABA in the absence of GABA B2 . Although this data does not completely discount the possibility that G-proteins may be interacting with il2 of the GABA B1 subunit, it does suggest that it is less likely that there are electrostatic interactions between GABA B1 and G-proteins. A recent study however has reported that replacement of the entire seven transmembrane and intracellular domains of GABA B1 with that of GABA B2 (termed GB1/2) reduces the efficacy of G-protein coupling to a "GB1/2 GB2" receptor (Galvez et al., 2001) . Although this may be indicative of a modulatory role for GABA B1 in G-protein coupling, we would suggest that it is more likely as a result of less efficient signaling between GABA B1 and its "downstream" partner, GABA B2 .
Molecular modeling studies have identified residues in the GABA B1 subunit that are critical for binding of GABA B agonists and antagonists, and these residues are absent from the GABA B2 subunit (Galvez et al., 2000a,b) . In this study, we demonstrated Figure 7 . GABA B2 expressed alone is unable to functionally couple to adenylate cyclase or bind GTP␥S in response to GABA, but substitution of the GABA B2 N terminus with that of GABA B1 abolishes GABA B receptor function. a, Membranes prepared from cells expressing either GABA B2 (GB2) alone (squares) or both GABA B1 (GB1) and GABA B2 together (circles, triangles) were incubated with either GABA (circles, squares) or baclofen (triangles) and subsequently with [
35 S]GTP␥S. Data are presented as the percentage of increase in [
35 S]GTP␥S binding over basal in response to agonist and are expressed as means Ϯ SEM (n ϭ 3). b, Cells expressing either GABA B2 alone or GABA B1 and GABA B2 together (symbols and legend as above) were incubated with forskolin and then either GABA or baclofen. Data are presented as the percentage of forskolin-stimulated cAMP levels remaining after incubation with agonist and are expressed as means Ϯ SEM (n ϭ 3). c, HEK293 cells were transiently transfected with GABA B1N/2 (GB1 N/2 ) and wtGABA B1 (GB1), and cell surface expression of GABA B subunits was examined by immunofluorescence using either an anti-myc antibody for GABA B1N/2 in the absence ( i) or presence (ii) of detergent or an anti-GABA B1 antibody for wtGABA B1 (iii). d, Representative FLIPR analysis showing no functional response to GABA in cells transiently transfected with G qi5 , GABA B1N/2 (GB1 N/2 ), and wtGABA B1 (GB1).
that GABA B2 expressed in the absence of GABA B1 in HEK293 cells is unable to respond functionally to GABA, by either inhibition of adenylate cyclase activity or binding of [ 35 S]GTP␥S. However, the absence of a ligand binding site does not necessarily mean that GABA B2 is not important in signal transduction. Indeed, the recent solving of the crystal structures for the N-terminal binding domain of mGluR1 demonstrate that movements between all four globular lobes of the N-terminal domains of the dimer are likely to cause shifts in transmembrane and intracellular domains, resulting in receptor activation (Kunishima et al., 2000) . These findings may help to explain results from this and other studies in which deletion or substitution of substantial parts of the GABA B2 N-terminal domain results in a complete loss of GABA B receptor function (Jones et al., 2000; Galvez et al., 2001) . This therefore suggests that the N-terminal domain of the GABA B2 subunit, although unable to bind GABA itself, may instead be involved in the conformational changes induced after ligand binding to the GABA B1 subunit.
In summary, our study has determined three residues within il2 of the GABA B2 subunit critical for G-protein signaling of the GABA B receptor heterodimer, demonstrating that this signaling absolutely requires the presence of the GABA B2 protein. Although our data do not rule out a possible involvement of GABA B1 in the signaling process, these studies, together with current knowledge of this receptor heterodimer, strongly suggest a novel mechanism of "sideways" signal transduction, whereby agonist binds to the GABA B1 subunit, resulting in a conformational change that is in some way passed on to the GABA B2 subunit, perhaps through its N-terminal and/or transmembrane domains. This in turn results in the receptor forming an activated state suitable for G-protein recruitment, via a direct interaction with GABA B2 , and thus downstream signal transduction (Fig. 8) . Such novel sideways signaling may allow increased complexity of receptor signal transduction, which may also be applicable to other GPCR heterodimers. Figure 8 . Proposed sideways signaling mechanism for the GABA B receptor heterodimer. GABA B1 (orange) and GABA B2 ( green) subunits form heterodimers via C-terminal coiled-coil interactions, as well as N-terminal and possibly transmembrane domain interactions. The agonist GABA binds to the ligand binding domain within the GABA B1 N terminus, resulting in a conformational change in the GABA B2 subunit. This activated state of the receptor heterodimer allows recruitment of G-proteins, at least in part via an interaction with the positively charged residues in il2 of GABA B2 and subsequent activation of downstream signal transduction cascades.
